Earnings
ONTXW
0.0671
0.00%
0.00
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
19.02M
--
--
37.00K
--
--
0.00
--
--
--
542.00K
180.00K
19.78M
52.00K
--
--
--
--
--
--
150.00K
202.00K
19.99M
--
4.83M
0.00
--
--
--
--
--
4.78M
--
--
--
408.00K
10.02M
0.00
--
--
--
3.79M
3.79M
13.81M
1.86M
432.86M
-428.56M
--
--
--
6.17M
6.17M
19.99M
FY 2019-12-31
22.73M
--
--
98.00K
--
--
0.00
--
--
--
510.00K
140.00K
23.47M
50.00K
--
--
--
--
--
--
150.00K
200.00K
23.67M
--
476.00K
0.00
--
--
--
--
--
7.35M
--
--
--
468.00K
8.29M
0.00
--
--
--
3.81M
3.81M
12.10M
1.11M
413.88M
-403.40M
--
--
0.00
11.57M
11.57M
23.67M
FY 2018-12-31
16.97M
--
--
35.00K
--
--
0.00
--
--
--
760.00K
--
17.77M
9000.00
--
--
--
--
--
--
149.00K
158.00K
17.92M
--
4.04M
0.00
--
--
--
--
--
4.17M
--
--
--
226.00K
8.44M
0.00
--
--
--
4.10M
4.10M
12.54M
57.00K
387.24M
-381.90M
--
--
0.00
5.39M
5.39M
17.92M
FY 2017-12-31
4.02M
--
--
59.00K
--
--
0.00
--
--
--
743.00K
77.00K
4.90M
64.00K
--
--
--
--
--
--
12.00K
76.00K
4.98M
--
6.19M
0.00
--
--
--
--
--
3.17M
--
--
--
620.00K
9.98M
0.00
--
--
--
5.86M
6.69M
15.84M
108.00K
350.51M
-362.32M
--
--
830.00K
-11.69M
-10.86M
4.98M
FY 2016-12-31
21.40M
--
--
31.00K
--
--
0.00
--
--
--
1.51M
123.00K
23.07M
152.00K
--
--
--
--
--
--
12.00K
164.00K
23.23M
--
5.32M
0.00
--
--
--
--
--
4.15M
--
--
--
690.00K
10.16M
0.00
--
--
--
7.95M
8.78M
18.11M
68.00K
342.48M
-338.22M
--
--
830.00K
4.30M
5.13M
23.23M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ONTXW latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze ONCONOVA THERAPE recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.